<?xml version="1.0" encoding="UTF-8"?>
<p>Therapy information was available for 249/303 patients, of which 121 were therapy-na√Øve (TN) at sampling time and 128 therapy-experienced (TE). All TE patients had received NRTIs. Twenty-two TE patients had undergone one zidovudine (AZT) monotherapy and 2 patients two AZT monotherapies. In addition, 65/128 (50.8%) patients had been treated with NNRTIs, 59/128 (46.1%) with PIs, and one (0.8%) with INSTIs.</p>
